LANNETT CO INC FDA Approval ANDA 204599

ANDA 204599

LANNETT CO INC

FDA Drug Application

Application #204599

Application Sponsors

ANDA 204599LANNETT CO INC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL2.5MG/5ML0LEVOCETIRIZINE DIHYDROCHLORIDELEVOCETIRIZINE DIHYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-05-15

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204599
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVOCETIRIZINE DIHYDROCHLORIDE","activeIngredients":"LEVOCETIRIZINE DIHYDROCHLORIDE","strength":"2.5MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/15\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-05-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.